Please assess the completion status of the following clinical trial:

Trial Title: Probiotics for the Prevention of Antibiotic-Associated Diarrhea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Participants will be children aged 1 year to 17 years admitted to the General Pediatric inpatient unit at The Hospital for Sick Children (Site 1) or McMaster Children's Hospital (Site 2).~2. Participants will be prescribed IV antibiotics with a planned duration of 1 or more days, and a total course of both IV and oral antibiotics, if applicable, of no more than 28 days.~3. Parent (if parent-report) or patient (if patient-report) is able to communicate in English (read, write, speak).~Exclusion Criteria:~1. Parental or patient (e.g. child \> 12 years old) report of current diarrhea, diarrhea within the last week.~2. Lactose intolerance.~3. Allergies to strawberry, dried citrus pulp, or any other components of the study product.~4. Immuno-compromised patients or those on immunosuppressive agents (e.g. heart or kidney transplant, complex care, sickle cell disease, chemotherapy agents, oral prednisone).~5. Patients with known or potentially compromised gut integrity (e.g. short gut, Inflammatory Bowel Disease, Celiac disease, Irritable Bowel Syndrome, nasogastric, nasojejunal or gastrostomy tube).~6. Children with serious and/or unstable medical conditions (e.g. diabetes, cardiovascular, renal, lung, psychiatric illness, bleeding disorders, etc.).~7. Children admitted to a medical or surgical subspecialty unit.~8. Patients enrolled in another study.~9. Patients previously randomized to this study.~10. Patient is pregnant.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Probiotic (BioK+) (Type: EXPERIMENTAL): Children will receive 10-40 billion CFUs/day of Bio-K+ (Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2), with dose based on their weight. The product will be administered as a strawberry flavored tub of milk.
- Placebo (Type: PLACEBO_COMPARATOR): Strawberry flavored tub of milk, identical (taste, color, odor) to the active Bio-K+ treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).